Cure My Disease

Don't miss your cure!

 Log in / Sign up

Peer navigators and mobile clinics aim to slash HIV rates in rural south african youth

NCT ID NCT05405582

Disease control Sponsor: Africa Health Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This trial tests a community-based approach to HIV prevention for young people aged 15-30 in rural KwaZulu-Natal, South Africa. Peer navigators guide participants to mobile clinics that offer sexual health services, including HIV testing, PrEP, and contraception. The goal is to reduce the number of youth with transmissible HIV by making prevention more accessible and tailored to individual risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Community-based HIV prevention including PrEP and sexual health services
What this could lead to
If successful, this approach could reduce new HIV infections among young people in rural areas and serve as a model for other communities.
What could go wrong
This is a large trial, but results depend on participation and real-world implementation. The intervention may not work as well outside this specific region.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

8,716 people

The number who actually took part.

Started

May 2022

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 30 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Resident in the cluster * Any gender * Aged 15-30 * If aged 18-30 and able and willing to consent to participate * If aged 15-17, able and willing to assent and whose guardian or parent are able and willing to consent to their participation. Exclusion Criteria: * Unable or unwilling to provide consent * Aged 14 or less * aged 31 or more

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV-1-infection are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease sexually transmitted disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV-1-infection Sexually transmitted diseases

Contacts and locations

Locations

  • Africa Health Research Institute

    Somkele, KwaZulu-Natal, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.